AngioDynamics (NASDAQ: ANGO) net income
AngioDynamics reported a net loss of $36.7m for fiscal 2026; in fiscal 2025 it reported a net loss of $34.0m. Earnings per share were −$0.88.
AngioDynamics's best year of the last 10 was fiscal 2019. It reported a loss in 7 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2026 | −$36.7m | — | −11.5% | −$0.88 |
| 2025 | −$34.0m | — | −11.6% | −$0.83 |
| 2024 | −$184.4m | — | −60.7% | −$4.59 |
| 2023 | −$52.4m | — | −15.5% | −$1.33 |
| 2022 | −$26.5m | — | −8.4% | −$0.68 |
| 2021 | −$31.5m | — | −10.8% | −$0.82 |
| 2020 | −$166.8m | −371.9% | −63.1% | −$4.39 |
| 2019 | $61.3m | +275.5% | 22.7% | $1.64 |
| 2018 | $16.3m | +226.2% | 6.2% | $0.44 |
| 2017 | $5.0m | — | 1.9% | $0.14 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
AngioDynamics net income compared with its sector
By net income for its latest fiscal year, AngioDynamics ranks 232nd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of AngioDynamics, −11.5%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 230th | Canton Strategic | −$35.9m | — |
| 231st | Context Therapeutics | −$36.1m | — |
| 232nd | AngioDynamics | −$36.7m | −11.5% |
| 233rd | Sanara Medtech | −$37.6m | −36.4% |
| 234th | Candel Therapeutics | −$38.2m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of AngioDynamics
- How much did AngioDynamics earn in fiscal 2026?
- AngioDynamics reported a net loss of $36.7m for fiscal 2026. In fiscal 2025 it reported a net loss of $34.0m.
- What are the earnings per share of AngioDynamics?
- They were −$0.88 in fiscal 2026, compared with −$0.83 in fiscal 2025.
- What was the most profitable year for AngioDynamics?
- Of its last 10 fiscal years, fiscal 2019, with $61.3m.
- Where does AngioDynamics rank in its sector by net income?
- It ranks 232nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for AngioDynamics come from?
- From the annual report (Form 10-K) that AngioDynamics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that AngioDynamics files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on AngioDynamics: the AngioDynamics page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.